> Detailanzeige

Bastard, Mathieu; Molfino, Lucas; Mutaquiha, Cláudia; Galindo, Miriam Arago; Zindoga, Pereira; Vaz, Deise; Mahinça, Ivan; DuCros, Philipp; Rusch, Barbara; Telnov, Alex

Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique
  • Beteiligte: Bastard, Mathieu; Molfino, Lucas; Mutaquiha, Cláudia; Galindo, Miriam Arago; Zindoga, Pereira; Vaz, Deise; Mahinça, Ivan; DuCros, Philipp; Rusch, Barbara; Telnov, Alex
  • Erschienen: Oxford University Press (OUP), 2019
  • Erschienen in: Clinical Infectious Diseases
  • Sprache: Englisch
  • DOI: 10.1093/cid/ciz196
  • ISSN: 1058-4838; 1537-6591
  • Schlagwörter: Infectious Diseases ; Microbiology (medical)
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title> <jats:p>Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched from injectable drug to bedaquiline suggest that a bedaquiline-based short regimen is effective and safe.</jats:p>
  • Zugangsstatus: Freier Zugang